Vor Biopharma
Clinical trials sponsored by Vor Biopharma, explained in plain language.
-
New drug trial aims to ease daily struggles of muscle weakness disease
Disease control Recruiting nowThis study tests a drug called telitacicept in 180 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo for 24 weeks to see if it improves daily activities like walking and talking. The goal is to contro…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated May 03, 2026 20:31 UTC
-
New hope for Sjögren's sufferers as drug enters final testing phase
Disease control Recruiting nowThis study tests an investigational drug called telitacicept in 250 adults with active primary Sjögren's disease, a chronic autoimmune condition causing dry eyes and mouth. Participants receive either the drug or a placebo for 48 weeks to see if it reduces disease activity. The g…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC